The Patent Finder

Terms ending in 2037

Genentech, Inc.

Every in-force patent on Genentech, Inc.'s record whose computed term ends in 2037, whoever holds it now. Soonest term end first, then patent number.
PatentTitleHolderStatusExpiresConfidence
US 10,877,042Anti-Hypusine Antibodies and Uses Thereof
In force
 · High confidence
Genentech, Inc.In forceHigh confidence
US 12,099,064Anti-Hypusine Antibodies and Uses Thereof
In force
 · High confidence
Genentech, Inc.In forceHigh confidence
US 11,692,043Peptidomimetic Compounds and Antibody-Drug Conjugates Thereof
In force
 · High confidence
MedImmune LimitedIn forceHigh confidence
US 11,535,671Therapeutic and Diagnostic Methods for Cancer
In force
 · High confidence
Genentech, Inc.In forceHigh confidence
US 11,337,852Therapeutic Agent Delivery Device
In force
 · High confidence
Genentech, Inc.In forceHigh confidence
US 10,323,094Humanized and Affinity Matured Antibodies to FCRH5 and Methods of Use
In force
 · High confidence
F. Hoffmann-La Roche AGIn forceHigh confidence
US 10,478,553Apparatus for Subretinal Administration of Therapeutic Agent via a Curved Needle
In force
 · High confidence
Genentech, Inc.In forceHigh confidence
US 10,246,461Dosage Form Compositions Comprising an Inhibitor of Bruton's Tyrosine Kinase
In force
 · High confidence
Genentech, Inc.In forceHigh confidence
US 11,365,197Dosage Form Compositions Comprising an Inhibitor of Bruton's Tyrosine Kinase
In force
 · High confidence
Genentech, Inc.In forceHigh confidence
US 10,219,936Therapeutic Agent Delivery Device with Advanceable Cannula and Needle
In force
 · High confidence
Genentech, Inc.In forceHigh confidence
54 more term ends in 2037 · Pro
10 of 64 patents shown. Soonest term end first, then patent number.
Pro members see all 64.
Upgrade to Pro
59 of these are in force and held by Genentech, Inc..
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited